Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

Christopher G. Goetz(Rush University Medical Center), Barbara C. Tilley(Medical University of South Carolina), Stephanie R. Shaftman(Medical University of South Carolina), Glenn T. Stebbins(Rush University Medical Center), Stanley Fahn(Columbia University), Pablo Martínez‐Martín(Instituto de Salud Carlos III), Werner Poewe(Innsbruck Medical University), Cristina Sampaio(University of Lisbon), Matthew B. Stern(University of Pennsylvania), Richard Dodel(Philipps University of Marburg), Bruno Dubois(Sorbonne Université), Robert G. Holloway(University of Rochester), Joseph Jankovic(Baylor College of Medicine), Jaime Kulisevsky(Hospital de Sant Pau), Anthony E. Lang(University of Toronto), Andrew J. Lees(University College London), Sue E. Leurgans(Rush University Medical Center), Peter A. LeWitt(Wayne State University), David L. Nyenhuis(University of Illinois Chicago), C. Warren Olanow(Icahn School of Medicine at Mount Sinai), Olivier Rascol(Pharmacochimie et Biologie pour le Développement), Anette Schrag(University College London), Jeanne A. Teresi(Columbia University), Jacobus J. van Hilten(Leiden University), Nancy R. LaPelle(University of Massachusetts Chan Medical School)
Movement Disorders
November 15, 2008
Cited by 7,460Open Access
Full Text

Abstract

We present a clinimetric assessment of the Movement Disorder Society (MDS)-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The MDS-UDPRS Task Force revised and expanded the UPDRS using recommendations from a published critique. The MDS-UPDRS has four parts, namely, I: Non-motor Experiences of Daily Living; II: Motor Experiences of Daily Living; III: Motor Examination; IV: Motor Complications. Twenty questions are completed by the patient/caregiver. Item-specific instructions and an appendix of complementary additional scales are provided. Movement disorder specialists and study coordinators administered the UPDRS (55 items) and MDS-UPDRS (65 items) to 877 English speaking (78% non-Latino Caucasian) patients with Parkinson's disease from 39 sites. We compared the two scales using correlative techniques and factor analysis. The MDS-UPDRS showed high internal consistency (Cronbach's alpha = 0.79-0.93 across parts) and correlated with the original UPDRS (rho = 0.96). MDS-UPDRS across-part correlations ranged from 0.22 to 0.66. Reliable factor structures for each part were obtained (comparative fit index > 0.90 for each part), which support the use of sum scores for each part in preference to a total score of all parts. The combined clinimetric results of this study support the validity of the MDS-UPDRS for rating PD.


Related Papers

No related papers found

Powered by citation graph analysis